BioSpace News Archive

Drug Development

Sensei Biotherapeutics Reports New Data from Phase 1 Clinical Trial of SNS-301

SNS-301 demonstrated a strong safety profile and promising immune responses in patients with biochemically recurrent prostate cancer SNS-301 is a first-in-class immunotherapy candidate emerging from Sensei’s SPIRIT platform that targets a novel embryonic antigen found on more than 20 types of cancers

June 5, 2018
·
4 min read
BioMidwest

You Don’t Need Sun to Feel the Burn This Summer

New Survey Finds Summertime is High Time for Frequent Heartburn and Approximately One-Third of Sufferers Would Give Up Their Social Media to Beat the Heat

June 5, 2018
·
4 min read
Business

Worldwide Clinical Trials Hires Veteran CRO Business Development Leader to Further Accelerate Company Success

Worldwide Clinical Trials, Inc. announced the addition of Chris Hill as its new Senior Vice President, International Business Development.

June 5, 2018
·
3 min read
Business

FamilyWize Partners with Personalized Medicine Company MedTek21

FamilyWize announced today a partnership that will give the public greater access to personalized medicine, helping patients better understand how their unique genetic profiles can influence how they metabolize certain medications.

June 5, 2018
·
5 min read
BioCapital

Neustar’s Digital Citizenship and STEM Advocacy Reaches 180,000 students across Virginia, California, Kentucky

Neustar® celebrated reaching 180,000 middle school students through its web-based My Connected World digital literacy and Science Technology Engineering Math (STEM) program.

June 5, 2018
·
2 min read
Policy

Asteres Inc. Receives Unanimous Approval from Texas Board of Pharmacy for ScriptCenter for 24/7 Prescription Pickup Kiosk

Asteres Inc. announced that the Texas Board of Pharmacy approved the use of ScriptCenter for 24/7 prescription pickup for all prescriptions in licensed and non-licensed facilities.

June 5, 2018
·
2 min read
Business

Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B

Hookipa and Gilead will jointly develop therapeutics against HIV and Hepatitis B infections; Hookipa and Gilead will jointly research and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead

June 5, 2018
·
5 min read
Business

Novus Announces Roll Out Strategy For Canada

Addresses Competitive Assessment With The Bigger Insurance Companies

June 5, 2018
·
10 min read
Dr. Reddy’s Laboratories Limited to Present at the Jefferies 2018 Healthcare Conference

Dr. Reddy’s Laboratories Ltd. announced that the Company will be presenting at the Jefferies 2018 Healthcare Conference

June 5, 2018
·
2 min read
Genetown

Infusion Nurses Society Announces Podcast Series

Infusion Nurses Society (INS) presents “Complications Happen,” a 6-part series presented by top infusion therapy experts, which addresses infusion therapy-related complications.

June 5, 2018
·
2 min read